Table 2.
Medication and comorbidities at initial presentation of 23 adult patients with gastroesophageal reflux disease (GERD) attending a dietetic practice in Townsville, Australia
| Total (n = 23) | Male(n = 12) | Female(n = 11) | |
|---|---|---|---|
| GERD medicationa | |||
| Number of patients using GERD medication at presentation | 18 (85.7%) | 7 (70.0%) | 11 (100%) |
| Number of patients using antacids | 2 (9.5%) | 1 (10.0%) | 1 (9.1%) |
| Number of patients using alginates | 1 (4.8%) | 1 (10.0%) | 0 |
| Number of patients using H2-antagonists | 11 (52.4%) | 4 (40.0%) | 7 (63.6%) |
| Number of patients using proton pump inhibitors | 5 (23.8%) | 1 (10.0%) | 4 (36.4%) |
| Comorbiditiesb | |||
| Number of overweight patientsc (BMId ≥ 25 and BMI ≤ 30) | 6 (30.0%) | 2 (18.2%) | 4 (44.4%) |
| Number of obese patientsc (BMI > 30) | 11 (55.0%) | 8 (72.7%) | 3 (33.3%) |
| Number of patients with hypertension | 8 (34.8%) | 5 (41.7%) | 3 (27.2%) |
| Number of patients with hyperlipidemia | 12 (52.2%) | 9 (75.0%) | 3 (27.2%) |
| Number of patients with history of coronary artery bypass surgery | 2 (8.7%) | 2 (16.7%) | 0 (0.0%) |
| Number of patients with non-insulin dependent diabetes mellitus or impaired glucose tolerance | 4 (17.4%) | 3 (25.0%) | 1 (9.0%) |
| Number of patients with diverticulitis or “bowel problems” | 4 (17.4%) | 3 (25.0%) | 1 (9.0%) |
| Number of patients with chronic pain | 2 (8.7%) | 2 (16.7%) | 0 (0.0%) |
| Number of patients with post traumatic stress disorder | 3 (13.0%) | 3 (25.0%) | 0 (0.0%) |
| Number of patients with gout | 1 (4.3%) | 1 (8.3%) | 0 (0.0%) |
| Number of patients with asthma | 1 (4.3%) | 0 (0.0%) | 1 (9.0%) |
| Number of patients with osteoporosis | 1 (4.3%) | 0 (0.0%) | 1 (9.0%) |
| Number of patients with migraines | 1 (4.3%) | 1 (8.3%) | 0 (0.0%) |
a
Notes: Some patients presented using more than one medication; information given is based on 21 patients;
b
Some patients had multiple comorbidities;
c
Weight was unavailable for 3 patients;
d
BMI, body mass index (kg/m2).